tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRQR Stock Latest News

ProQR Reports Q3 2025 Financial Results Amid Revenue Decline
Company AnnouncementsProQR Reports Q3 2025 Financial Results Amid Revenue Decline
10d ago
6K
PRQR
ProQR Therapeutics reports Q3 (EUR 0.10) vs (EUR 0.10) last year
PremiumThe Fly
ProQR Therapeutics reports Q3 (EUR 0.10) vs (EUR 0.10) last year
10d ago
PRQR
ProQR Positioned for Growth: Strategic Advancements and Clinical Milestones in RNA Editing
PremiumRatings
ProQR Positioned for Growth: Strategic Advancements and Clinical Milestones in RNA Editing
12d ago
PRQR
ProQR Advances AX-0810 into Clinical Trials for Cholestatic Diseases
PremiumCompany Announcements
ProQR Advances AX-0810 into Clinical Trials for Cholestatic Diseases
12d ago
6K
PRQR
PRQR Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PRQR Upcoming Earnings Report: What to Expect?
13d ago
PRQR
ProQR Receives CTA Authorization for AX-0810 and Plans Investor Event
PremiumCompany AnnouncementsProQR Receives CTA Authorization for AX-0810 and Plans Investor Event
26d ago
6K
PRQR
ProQR Therapeutics receives CTA authorization for AX-0810
Premium
The Fly
ProQR Therapeutics receives CTA authorization for AX-0810
27d ago
PRQR
ProQR Therapeutics management to meet with Citizens JMP
Premium
The Fly
ProQR Therapeutics management to meet with Citizens JMP
1M ago
PRQR
ProQR Therapeutics Advances RNA Therapy Pipeline
PremiumCompany Announcements
ProQR Therapeutics Advances RNA Therapy Pipeline
3M ago
PRQR
ProQR’s Strategic Advancements and Promising RNA Editing Platform Earns Buy Rating
PremiumRatings
ProQR’s Strategic Advancements and Promising RNA Editing Platform Earns Buy Rating
3M ago
PRQR
ProQR’s Strategic Advancements and Clinical Prospects Drive Buy Rating
PremiumRatings
ProQR’s Strategic Advancements and Clinical Prospects Drive Buy Rating
3M ago
PRQR
ProQR Reports Q2 2025 Financial Results Amid Rising R&D Costs
PremiumCompany Announcements
ProQR Reports Q2 2025 Financial Results Amid Rising R&D Costs
3M ago
6K
PRQR
ProQR Therapeutics reports Q2 EPS (EUR 0.21) vs. (EUR 0.13) last year
PremiumThe FlyProQR Therapeutics reports Q2 EPS (EUR 0.21) vs. (EUR 0.13) last year
3M ago
PRQR
ProQR Therapeutics sees cash runway into mid-2027
Premium
The Fly
ProQR Therapeutics sees cash runway into mid-2027
3M ago
PRQR
ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI
Premium
The Fly
ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI
4M ago
PRQR
ProQR Submits CTA for Phase 1 Study of AX-0810
PremiumCompany Announcements
ProQR Submits CTA for Phase 1 Study of AX-0810
5M ago
6K
PRQR
ProQR Shareholders Approve Key Resolutions at Annual Meeting
PremiumCompany Announcements
ProQR Shareholders Approve Key Resolutions at Annual Meeting
6M ago
6K
PRQR
ProQR Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
ProQR Therapeutics Reports Q1 2025 Financial Results
6M ago
PRQR
ProQR Therapeutics price target lowered to $9 from $15 at Oppenheimer
PremiumThe Fly
ProQR Therapeutics price target lowered to $9 from $15 at Oppenheimer
6M ago
PRQR
ProQR’s Innovative RNA Editing Platform and Promising AX-0810 Program Drive Buy Rating
PremiumRatingsProQR’s Innovative RNA Editing Platform and Promising AX-0810 Program Drive Buy Rating
6M ago
PRQR
ProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs
Premium
Company Announcements
ProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs
6M ago
6K
PRQR
ProQR Therapeutics reports Q1 EPS (EUR 0.10) vs (EUR 0.09) last year
Premium
The Fly
ProQR Therapeutics reports Q1 EPS (EUR 0.10) vs (EUR 0.09) last year
6M ago
PRQR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >